RxRegimen check replace synthesize
Back to Library
FDA LABEL GENERIC: Capsaicin MFR: Preferred Pharmaceuticals Inc.

Lidopro (capsaicin 0.0325 % / Lidocaine Hcl 4 % / Menthol 10 % / Methyl Salicylate 27.5 % ) Topical Ointment

Active Ingredient

Capsaicin 0.0325%

Purpose

Counterirritant

Active Ingredient

Lidocaine HCL 4%

Purpose

Topical Anesthetic

Active Ingredient

Menthol 10%

Purpose

Topical Analgesic

Active Ingredient

Methyl Salicylate 27.5%

Purpose

Counterirritant

Uses

For the temporary relief of joint pain and muscle pain associated with:

Arthritis Simple Backache Muscle Sprains Muscle Strains

Warnings

For External Use Only

Do Not Use

On damaged, irritated, or infected skin
With a bandage or heating pad
If you are allergic to any ingredients in this product

When Using This Product:

Avoid contact with eyes and mucus membranes

Stop Use and Ask a Doctor If:

Conditions worsens Excessive skin irritation develops Symptoms persist for more than 7 days, or symptoms clear up and occur again within 3 days

If Pregnant orBreast-Feeding:

Ask a health professional before use.

Keep Out of Reach of Children:

If ingested seek medical help or contact a Poison Control Center immediately

Flammable:

Keep away from excessive heat or open flame

Directions

Adults and Children 12 Years of Age and Older:

Clean and dry the affected area Apply product directly to your skin, up to 4 times daily affected area Wash hands immediately after use

Children Under 12 Years of Age: Consult physician

Other Information

Store in a cool, dry place with lid tightly closed If the tamper-evident foil seal is not intact, do not use

Inactive Ingredients

Allantoin, Aloe Barbadensis Leaf Juice, Ammonium Acryloyldimethyltaurate/VP Copolymer, Cetyl Alcohol, Chamomilla Recutita Matricaria Flower Extract, Dimethicone, Disodium EDTA, Ethylhexylglycerin, Glycerin, Glyceryl Stearate, Inulin Lauryl Carbamate, PEG-100 Stearate, Phenoxyethanol, Stearic Acid, Triethanolamine, Water.

Questions or Comments?

[email protected]

Relabeled By: Preferred Pharmaceuticals Inc.

Principal Display Panel

NDC 53225-1020-1

Preferred Pharmaceuticals Inc. NDC 68788-8314-1